ArticlePharmaceutics2023

Chimeric Peptide Engineered Nanomedicine for Synergistic Suppression of Tumor Growth and Therapy-Induced Hyperlipidemia by mTOR and PCSK9 Inhibition.

Hua Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.